Skip to main content
IMVT
NASDAQ Life Sciences

Immunovant Posts Narrower-Than-Expected Q2 Loss of $97.2M

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$28.1
Mkt Cap
$6.306B
52W Low
$21.43
52W High
$45.42
52W Position info
31% above low
Off High info
38% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

IMVT sits 31% above its 52-week low of $21.43 on elevated volume (1.9× avg).

Summary

Immunovant reported a Q2 net loss of $97.246 million, well narrower than the IBES estimate of a $152.9 million loss. Operating expenses came in at $104.155 million and basic EPS was -$0.47. The narrower loss is a modest positive, but the real story for this name remains the IMVT-1402 program after the September CLE proof-of-concept study missed its primary endpoint. Cash burn is the number that matters here: the prior quarter posted a $153.2 million net loss on surging R&D, so a lighter Q2 loss suggests spending is coming in below the prior run rate.

At the time of this announcement, IMVT was trading at $28.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.3B. The 52-week trading range was $21.43 to $45.42. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

IMVT - Latest Insights

IMVT
Nov 09, 2026, 7:20 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $35.20
Real-time Price: $35.50 info
Change: +$0.300 (+0.85%) info
Market Cap: $6.306B info
IMVT
Nov 09, 2026, 7:09 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $35.85
Real-time Price: $35.50 info
Change: -$0.350 (-0.98%) info
Market Cap: $6.306B info
IMVT
Nov 09, 2026, 7:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $28.10
Real-time Price: $35.50 info
Change: +$7.40 (+26%) info
Market Cap: $6.306B info
IMVT
Sep 23, 2026, 7:01 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $36.20
Real-time Price: $35.50 info
Change: -$0.700 (-2%) info
Market Cap: $6.306B info
IMVT
Aug 07, 2026, 3:15 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $39.74
Real-time Price: $35.50 info
Change: -$4.24 (-11%) info
Market Cap: $6.306B info